FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:714 February 28, 2002 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

(New Frontiers in Cancer Therapy.) Edited by Bruce D. Cheson. 287 pp. Abingdon, United Kingdom, Darwin Scientific, 2001. $95. ISBN 1-903557-01-1.

A variety of hematologic cancers have served as examples of how to cure the disease by a step-by-step application of new treatments as they become available, but it must be admitted that during the past 10 years there have been no real breakthroughs in the fields of conventional chemotherapy, radiotherapy, or even marrow-ablative treatment followed by transplantation of stem cells. On average, half the patients eligible for the most effective treatment are cured, but the other half, with disease that is less responsive to treatment, still has a most unfavorable prognosis. Apparently, the limits of the possible have been reached . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.